Eris Lifesciences Ltd (NSE:ERIS) Q4 2025 Earnings Call Highlights: Robust Revenue Growth Amidst ...
Release Date: May 19, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Eris Lifesciences Ltd (NSE:ERIS) reported a 28% year-on-year growth in consolidated operating revenue for Q4, reaching INR 705 crores.
The company achieved a significant 70% year-on-year growth in consolidated EBITDA, amounting to INR 252 crores.
Eris Lifesciences Ltd (NSE:ERIS) saw a 28% growth in profit after tax, totaling INR 102 crores for the quarter.
The company reported a strong operating cash flow to EBITDA ratio of 111% in Q4.
The return on capital employed (ROCE) improved to 15% for FY25, up from 11% in the previous year, with an adjusted ROCE of 20%.
There was a significant product shortage in human insulin, resulting in an estimated sales loss of around INR 50 crores.
The critical care segment experienced a planned 20% decline, attributed to delays in building out the domestic go-to-market strategy.
The company faced challenges in the oncology business due to product mix issues, impacting performance.
Insulin fill-in took longer than anticipated, affecting the rollout of certain products.
The company experienced intermittent connection issues during the earnings call, leading to unclear communication at times.
Warning! GuruFocus has detected 8 Warning Signs with NSE:ERIS.
Q: Can you clarify the impact of the supply shortage on the insulin business and the expected market capture? A: We experienced a sales loss of around INR 50 crore due to supply shortages, with INR 38 crore within the Biocon One business. We are confident in capturing 50-60% of the vacated market, supported by a secured supply deal and upcoming capacity expansions. (Respondent: Unidentified_3)
Q: What are the challenges faced in the critical care business, and how do you plan to address them? A: The critical care segment faced issues due to a lack of market strategy and bandwidth. We are working on improving our go-to-market strategy and expect to see improvements in the next quarter. (Respondent: Unidentified_3)
Q: Why is there a discrepancy in the expected margin improvements despite significant growth in the insulin business? A: The expected margin improvements are tempered by the timing of cartridge production, which will start in Q4, and the addition of 300 new employees, which initially strains the EBITDA line. We are cautiously guiding a 37% margin. (Respondent: Unidentified_3)
Q: How does Eris plan to fill the gap left by Novo's exit from the insulin cartridge market? A: We believe the substitutes offered by Novo are either reverting to vials or are significantly more expensive. We expect to capture a significant portion of the market due to our competitive pricing and established brands. (Respondent: Unidentified_3)
Q: What are the next steps for Swiss Parentals in terms of export opportunities and CDMO contracts? A: We are awaiting N visa approval, which will open large markets for us. We are in discussions for CDMO contracts, focusing on specialty injectables for EU clients, with plans to expand into oral solids. (Respondent: Unidentified_3)
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
18 minutes ago
- Forbes
New Apple ‘Lessons' Ad Highlights Student Learning As Mac Sales Grow In India
Apple Lessons ad Apple Apple MacBooks are arguably one of the best options for students, and the Cupertino giant is highlighting this in its new ad for India. Released on June 4, the new Lessons ad focuses on how students can use a Mac to 'level up' and make the most of their studies. This comes at a time when M4 Mac sales have seen double-digit growth in a quarter. The new Lessons ad encourages students to try different approaches to learning instead of mugging up answers. It showcases a few Apple Intelligence features like Summary in Writing Tools to turn a lengthy note into short bullet points, and how the MacBook Air M4 allows students to run multiple engineering applications, including AutoCAD, MATLAB, and more simultaneously. According to a report from Counterpoint, Apple saw 17% YoY growth in the global PC market shipments in Q1 2025. It was driven by M4 series Macs. In India, Apple had a 6% PC market share with 29% growth in 2024. The Cupertino tech giant has seen very strong momentum for its MacBook sales in the country—and there are various reasons for it. 'Education as a segment is increasing. Young professionals and even young students are opting for Macs, especially after the launch of their M series chipsets, because a lot of people believe and correlate that to performance and efficiency gains, which they offer,' says Tarun Pathik, Research Director at Counterpoint. The consumer financing and discounts on Apple products are also playing a major part in MacBook adoption in India. 'That [consumer financing and discounts] is one of the reasons why iPhone sales are growing in India at one of the fastest rates in the world,' he added. 'And this has led to an increase in Mac sales. We have always seen a very healthy step-by-step entry into the Apple ecosystem.' The first point of entry into the Apple ecosystem is the iPhone, which is followed by the AirPods, Apple Watch, iPad, and eventually a Mac. 'We are seeing that transition of such users who entered through iPhone a couple of years back and now they are reaching the level three or four to buy a Mac,' explains Pathik. While Apple is focusing on the education segment with its new ad, the Cupertino giant is also forming corporate partnerships that have contributed to its Mac growth. 'Indian companies like Zoho and Wipro have integrated Macs into their operations, which has increased Apple's enterprise adoption,' he said. With education and enterprise both driving momentum, Apple's Mac strategy in India seems to be working. The new Lessons ad is a timely push to deepen that growth.
Yahoo
34 minutes ago
- Yahoo
HCLTech Grant Americas second edition awards $1 million to three NGOs to create scalable solutions to combat climate change
NEW YORK and NOIDA, India, June 5, 2025 /CNW/ -- HCLTech (NSE: (BSE: a leading global technology company, announced Osa Conservation as the winner and Daily Acts and Ocean Wise as the two runners-up of the second edition of the HCLTech Climate Action Grant in the Americas. The three non-government organizations (NGOs) will be awarded a total of $1 million to help build scalable, sustainable solutions to drive climate action across the Americas. In the second year, applications increased by more than 70%, and after several rounds of review and rigorous due diligence, HCLTech selected Osa Conservation to receive $500,000 and Daily Acts and Ocean Wise to receive $250,000 each. This year's registrations increased by 34% from the 10 eligible countries across the Americas, including Argentina, Brazil, Canada, Colombia, Costa Rica, Guatemala, Mexico, Panama, Peru and the U.S. Osa Conservation, based in Costa Rica, will focus its grant award on Climate Lifeboat corridors, which help species migrate and thrive amid climate change. By reconnecting fragmented tropical habitats, the project supports climate adaptation while safeguarding ecosystems across millions of acres. California-based Daily Acts will use its grant for its community-powered climate resilience initiative. The project blends government strategy with grassroots action to advance water management, stormwater mitigation and social infrastructure across neighborhoods in Petaluma, Calif. and beyond. Canada-based Ocean Wise will dedicate its grant to its kelp forest restoration project on the Pacific coast. By managing urchin overpopulation and combining advanced technology and ecological research, the project aims to strengthen marine biodiversity and support coastal communities. "We are excited to support this year's recipients of the HCLTech Grant Americas as they expand their innovative projects to reconnect natural habitats, boost community resilience and rejuvenate marine ecosystems across the Americas," said Dr. Nidhi Pundhir, Senior Vice President, Global CSR, HCLTech. "This year, we saw a substantial increase in applications, highlighting the urgency of mitigating the adverse effects of climate change and the importance of supporting initiatives that pave the way for a sustainable future." In its inaugural year in 2023, HCLTech Climate Action Grant in the Americas committed $5 million in grants over five years to support sustainable solutions to fight the climate crisis across the Americas. The Grant in the Americas builds on HCLTech and the HCLFoundation (HCLTech's CSR arm) focus on continuous global sustainability commitment with a total investment of over $175 million in CSR programs to date. HCLTech is consistently recognized for its commitment to making a positive difference in the environment. Through our technology and collective expertise, HCLTech was recognized as an Industry Mover by S&P Global Sustainability Yearbook 2023 for sustainable business practices and continues to partner with leading U.S.-based organizations, including Feeding America and Girl Up, to serve the broader community. For more information on HCLTech Climate Action Grant in the Americas, its mission and the application process, please visit About HCLTech HCLTech is a global technology company, home to more than 223,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud and AI, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, High Tech, Semiconductor, Telecom and Media, Retail and CPG and Public Services. Consolidated revenues as of 12 months ending March 2025 totaled $13.8 billion. To learn how we can supercharge progress for you, visit For further details, please contact: Meredith Bucaro, Americasmeredith-bucaro@ Elka Ghudial, James Galvin, Nitin Shukla, Indianitin-shukla@ Logo - View original content to download multimedia: SOURCE HCLTech View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
35 minutes ago
- Forbes
Why Medicaid Needs A Text Message Exemption Now
Man standing outside, texting. (Photo by) A fierce debate rages over the Big, Beautiful Bill (BBB) and its impact on Medicaid beneficiaries. While House Speaker Mike Johnson recently claimed millions "will not lose their Medicaid unless they choose to do so," the reality is the bill's work requirements will create administrative barriers that will result in coverage losses due to poorly informed Medicaid beneficiaries. These communication barriers can be addressed by modifications to the Telephone Consumer Protection Act (TCPA). The TCPA, a decades-old law governed by the Federal Communications Commission (FCC), prohibits automated text messages without prior consent. The law has created a culture of confusion and risk aversion in healthcare administration. Healthcare administrators like lawyers and compliance officers view text messaging as a litigation minefield, while patients and families who need timely, accessible communication freely use digital messaging for everything else. This creates a glaring disconnect: people communicate through text messaging across all demographics, including Medicaid beneficiaries, yet Medicaid managed care organizations and state agencies continue relying on antiquated communication methods because they fear litigation from murky TCPA regulations. The FCC has already provided guidance permitting digital communication for Medicaid eligibility and enrollment. However, this guidance needs to extend further and establish an explicit, indisputable exemption for all Medicaid programs and Medicaid-related services. This clarity will provide authority that helps prevent unnecessary coverage losses due to communication failures. It will also lead to a welcome alignment between how health agencies communicate and how people want to communicate. As new work requirements loom, we can either continue prioritizing risk management gray areas over beneficiary communication needs, or we can adapt our approaches to align with the digital channels people use and prefer. We don't need to speculate about the impact of poor communication with beneficiaries because we witnessed it recently. During the 2023 Medicaid redetermination process, people were required to re-enroll to demonstrate their eligibility. The problem wasn't eligibility; it was communication. According to Kaiser, half of Medicaid enrollees were unaware of the process or knew little about it. Millions lost coverage not because they were ineligible, but because they didn't know about re-enrollment deadlines or couldn't navigate the bureaucratic documentation requirements. Many only discovered they'd lost coverage when they showed up for medical care. These coverage losses were avoidable with better, more efficient communication. After 25 years serving a patient population that is 90-95% Medicaid beneficiaries, I understand these are busy people juggling multiple responsibilities. The majority work in gig economy jobs, minimum wage positions, or jobs that don't provide affordable health insurance. Many work multiple jobs and communicate primarily via text message. When Medicaid agencies rely on outdated methods like snail mail and email, critical information gets lost. We have an excellent, accessible tool to address these communication inefficiencies. It is text messaging and we are afraid to use it. To address texting limitations and improve communication with the Medicaid population, Abner Mason, a digital health entrepreneur and longtime advocate for text messaging in healthcare, aims to establish the Medicaid Texting Coalition. The coalition will collaborate with and advise federal agencies to exempt Medicaid from TCPA restrictions. Mason says, "Texting is the primary and preferred mode of communication for all Americans, including Medicaid beneficiaries, and we must use it to improve health outcomes and, if the time comes, to allow efficient communication to verify work status." If we care about reducing the impact of the BBB on Medicaid enrollment, an obvious and politically feasible strategy is to exempt Medicaid programs from TCPA restrictions immediately. The technology exists and the solution is straightforward. Medicaid needs a TCPA exemption now because the freedom to text is among our best hopes for minimizing the unnecessary impacts of potential work requirements.
